menu search

Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights

Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights
PDUFA date of May 19, 2023 Presented clinical data at ARVO on topical application of B-VEC to the eye to treat ocular complications in a patient with recessive dystrophic epidermolysis bullosa under Compassionate Use Program Strong balance sheet, closing the quarter with $355.5 million in cash, cash equivalents and investments PITTSBURGH, May 08, 2023 (GLOBE […] The post Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights appeared first on ForexTV... Read More
Posted: May 8 2023, 12:23
Author Name: forextv
Views: 102439

Search within

Pages Search Results: